sucujovide.wordpress.com
The biotechnology company reported a net lossof $6.5 or 32 cents a on revenue of $8,000 for the quarter ended Sept. 30. Last year over the same the company reported a net lossof $6.9 or 34 cents a on revenue of $140,000. Analysts surveyed by Thomsonn First Call estimated a net loss of 33 Total operating expenses for the most recent quarterwas $6.9 compared to $7.7 million for the same period in 2003.
In the company announced a restructuring andlayoffd plan, cutting its work force by 40 In a statement, Kenneth Chahine, the company'd chief executive officer, said that the quarter's financialo results are in line with managementy expectations and consistent with the company's realigned producf development strategy. As of Sept. 30, the companty had approximately $81 million in cash equivalents, available-for-sale securities and restricter investments. Shares of the company (NASDAQ: AVGN) were up 6.7 percen to $3.37 at midday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment